Home/Filings/4/0001179110-18-001813
4//SEC Filing

Parker Katherine 4

Accession 0001179110-18-001813

CIK 0001235007other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:45 PM ET

Size

7.7 KB

Accession

0001179110-18-001813

Insider Transaction Report

Form 4
Period: 2018-02-08
Parker Katherine
VP of Human Resources
Transactions
  • Award

    Common Stock

    2018-02-08+12,50077,120 total
  • Award

    Stock Option (right to buy)

    2018-02-08+25,00025,000 total
    Exercise: $3.01Exp: 2028-02-08Common Stock (25,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    1,200
Footnotes (3)
  • [F1]Represents restricted stock units that will vest and be paid 1/4 annually over a period of 4 years beginning on 2/8/19, in the form of one share of common stock for each restricted stock unit.
  • [F2]Includes 1511 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on December 15, 2017.
  • [F3]Shares subject to the option vest 1/4 annually over a 4 year period beginning 2/8/19.

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeother

Related Parties

1
  • filerCIK 0001633299

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:45 PM ET
Size
7.7 KB